Synlogic Appoints Michael Heffernan to its Board of Directors
- Wednesday, December 9, 2020, 7:02
- Finance
- Add a comment
CAMBRIDGE, Mass., Dec. 9, 2020 /PRNewswire/ — Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the appointment of Michael Heffernan to its board of directors. “We are delighted to welcome Mike…
About the Author
adminasapcorp has written 41811 stories on this site.